Log In
Print
BCIQ
Print
Print this Print this
 

Cx601

  Manage Alerts
Collapse Summary General Information
Company TiGenix N.V.
DescriptionAllogeneic expanded adipose derived stem cells
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase III
Standard IndicationCrohn's disease
Indication DetailsTreat anal fistula; Treat complex perianal fistulas in Crohn's disease (CD) patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today